Web Results

junobiomedical.com

Juno Biomedical, Inc. About Us ... “Juno Biomedical's technology opens a new frontier in treating currently untreatable and disabling conditions such as stroke."

www.linkedin.com/company/juno-biomedical-inc-

Learn about working at Juno Biomedical, Inc.. Join LinkedIn today for free. See who you know at Juno Biomedical, Inc., leverage your professional network, and  ...

clinicaltrials.gov/ct2/show/NCT03436771

Feb 19, 2018 ... Responsible Party: Juno Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT03436771 History of Changes. Other Study ID Numbers: LTFU001.

www.sec.gov/Archives/edgar/data/1594864/000159486417000009/juno-123116x10k.htm

For the fiscal year ended December 31, 2016. OR ... Juno Therapeutics, Inc. ...... application for filing, or, if the application relates to an unmet medical need in a ...

www.junotherapeutics.com/about-us/our-values

We're on a quest to radically change the course of medicine by aligning our investments in research, manufacturing & people to change the way we treat ...

www.junotherapeutics.com/our-pipeline

Juno is planning to evaluate multiple product candidates in Phase 1 trials for common types of relapsed or refractory (R/R) B cell NHL of both aggressive and ...

www.geekwire.com/2013/cancer-research-startup-juno-therapeutics-raises-120m-largest-series-vc-deals

Dec 3, 2013 ... The cancer research company is a spin out of the Fred… ... long-term remissions and reduce or eliminate the need for debilitating surgery, radiation and chemotherapy. ... Juno Therapeutics Inc., a new biotechnology company focused on .... on cancer treatment and biomedical research around the world.

www.crunchbase.com/organization/juno-therapeutics

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the ... UNO THERAPEUTICS, INC. ... Juno Therapeutics acquired by Celgene.

www.seattletimes.com/business/technology/juno-therapeutics-suspends-drug-trial-after-patient-death

Nov 23, 2016 ... Juno Therapeutics said it has suspended a clinical trial of a cancer drug ... The company's “Rocket” trial for B cell acute lymphoblastic leukemia — or ... neurotoxicity or cerebral edema,” Chief Medical Officer Mark Gilbert said ...